| 1 | Follicular cyst | 28.6% |
| 2 | Mucocele | 28.6% |
| 3 | Pancreatic Insufficiency | 28.6% |
| 4 | Pancreatitis | 28.6% |
| 5 | Pilonidal Cyst | 28.6% |
| 6 | Thyroglossal Cyst | 28.6% |
| 7 | Synovial Cyst | 28.6% |
| 8 | Dermoid Cyst | 25.2% |
| 9 | Pancreatic Fistula | 22.4% |
| 10 | Choledochal Cyst | 22.1% |
| 11 | Pancreatic Neoplasm | 22% |
| 12 | Lymphocele | 21.4% |
| 13 | Breast Cyst | 21.1% |
| 14 | Mediastinal Cyst | 21.1% |
| 15 | Parovarian Cyst | 21.1% |
| 16 | Pericardial Cyst | 21.1% |
| 17 | Thymic Cyst | 21.1% |
| 18 | Myxoid cyst | 21.1% |
| 19 | Pancreatitis, Chronic | 20.9% |
| 20 | Digestive System Neoplasms | 18.5% |
| 21 | Corpus Luteum Cyst | 16.5% |
| 22 | Ovarian Cysts | 16.5% |
| 23 | Peritoneal Neoplasms | 16.3% |
| 24 | Carcinoma, Pancreatic Ductal | 15.8% |
| 25 | Gastrointestinal Neoplasms | 15.5% |
| 26 | Liver neoplasms | 15.5% |
| 27 | Pancreatitis, Alcoholic | 15.4% |
| 28 | Biliary Tract Diseases | 15% |
| 29 | Gastrointestinal Diseases | 15% |
| 30 | Hamartoma | 15% |
| 31 | Liver diseases | 15% |
| 32 | Neoplasms, Hormone-Dependent | 15% |
| 33 | Neoplasms, Multiple Primary | 15% |
| 34 | Paraneoplastic Syndromes | 15% |
| 35 | Precancerous Conditions | 15% |
| 36 | Neoplasms, Second Primary | 15% |
| 37 | Zollinger-Ellison syndrome | 14.7% |
| 38 | Cystic Fibrosis | 14.3% |
| 39 | Esophageal Neoplasms | 14% |
| 40 | Congenital Hyperinsulinism | 13.8% |
| 41 | insulinoma | 13.8% |
| 42 | Gastrinoma | 13.6% |
| 43 | Glucagonoma | 13.6% |
| 44 | Vipoma | 13.6% |
| 45 | Bile Duct Neoplasms | 13% |
| 46 | gallbladder neoplasm | 13% |
| 47 | Intestinal Neoplasms | 13% |
| 48 | Stomach Neoplasms | 13% |
| 49 | Hepatocellular Adenoma | 12.4% |
| 50 | Barrett Esophagus | 12.3% |
| 51 | Colorectal Neoplasms | 12.2% |
| 52 | Liver Neoplasms, Experimental | 12.1% |
| 53 | Polycystic Ovary Syndrome | 12.1% |
| 54 | Carcinoma 256, Walker | 11.9% |
| 55 | Adenomatous Polyposis Coli | 11.9% |
| 56 | Cecal Neoplasms | 11.6% |
| 57 | Duodenal Neoplasms | 11.6% |
| 58 | Gastrointestinal Stromal Tumors | 11.6% |
| 59 | Carcinoma, Ehrlich Tumor | 11.3% |
| 60 | Carcinoma, Lewis Lung | 11.3% |
| 61 | Biliary cirrhosis | 11.2% |
| 62 | Neoplastic Processes | 11.1% |
| 63 | Neoplastic Syndromes, Hereditary | 11.1% |
| 64 | Pregnancy Complications, Neoplastic | 11.1% |
| 65 | Proctocolitis | 11.1% |
| 66 | Multiple Endocrine Neoplasia | 11% |
| 67 | Neoplasms, Experimental | 10.9% |
| 68 | Neoplasms, Neuroepithelial | 10.8% |
| 69 | Gliomatosis cerebri | 10.8% |
| 70 | Medulloblastoma | 10.6% |
| 71 | Appendiceal Neoplasms | 10.4% |
| 72 | Colonic Neoplasms | 10.4% |
| 73 | Rectal Neoplasms | 10.4% |
| 74 | Anus Neoplasms | 10.4% |
| 75 | Sigmoid Neoplasms | 10.4% |
| 76 | Dysentery | 10.3% |
| 77 | Enteritis | 10.3% |
| 78 | Enterocolitis | 10.3% |
| 79 | Esophageal and Gastric Varices | 10.3% |
| 80 | Esophagitis | 10.3% |
| 81 | Gastritis | 10.3% |
| 82 | Inflammatory Bowel Diseases | 10.3% |
| 83 | Neuroectodermal Tumors | 10.3% |
| 84 | Cholecystolithiasis | 10.3% |
| 85 | Melanoma, Experimental | 10.3% |
| 86 | Duodenitis | 10.1% |
| 87 | Ileitis | 10.1% |
| 88 | melanoma | 10.1% |
| 89 | Erosive Duodenitis | 10.1% |
| 90 | Nesidioblastosis | 10.1% |
| 91 | Paraneoplastic Encephalomyelitis | 9.9% |
| 92 | Mesenteric vascular insufficiency | 9.9% |
| 93 | Esophageal Atresia | 9.7% |
| 94 | Intestinal Atresia | 9.7% |
| 95 | Mesenteric Vascular Occlusion | 9.7% |
| 96 | Trophoblastic Neoplasms | 9.7% |
| 97 | Intestinal Fistula | 9.7% |
| 98 | Leukemia, Experimental | 9.7% |
| 99 | Mammary Neoplasms, Experimental | 9.7% |
| 100 | Enterocutaneous Fistula | 9.7% |
| 101 | Abdominal Neoplasms | 9.5% |
| 102 | Bile Duct Diseases | 9.5% |
| 103 | Cholelithiasis | 9.5% |
| 104 | Chylous Ascites | 9.5% |
| 105 | Erythroplasia | 9.5% |
| 106 | Esophageal Diseases | 9.5% |
| 107 | Fatty Liver | 9.5% |
| 108 | Gastroenteritis | 9.5% |
| 109 | Head and Neck Neoplasms | 9.5% |
| 110 | Hepatitis | 9.5% |
| 111 | Portal Hypertension | 9.5% |
| 112 | Intestinal Diseases | 9.5% |
| 113 | leukemia | 9.5% |
| 114 | Liver Cirrhosis | 9.5% |
| 115 | Neoplasms, Germ Cell and Embryonal | 9.5% |
| 116 | Neoplasms, Glandular and Epithelial | 9.5% |
| 117 | Pneumoperitoneum | 9.5% |
| 118 | Soft Tissue Neoplasms | 9.5% |
| 119 | Stomach Diseases | 9.5% |
| 120 | Thoracic Neoplasms | 9.5% |
| 121 | Focal Nodular Hyperplasia | 9.5% |
| 122 | Germ Cell Cancer | 9.5% |
| 123 | Hepatic Insufficiency | 9.5% |
| 124 | Aberrant Crypt Foci | 9.5% |
| 125 | Steatohepatitis | 9.5% |
| 126 | Carcinosarcoma | 9.4% |
| 127 | Colitis | 9.4% |
| 128 | Duodenogastric Reflux | 9.4% |
| 129 | Hemangiosarcoma | 9.4% |
| 130 | Leukemia L1210 | 9.4% |
| 131 | Leukemia P388 | 9.4% |
| 132 | lymphangiosarcoma | 9.4% |
| 133 | Peptic Ulcer | 9.4% |
| 134 | Proctitis | 9.4% |
| 135 | Choledocholithiasis | 9.4% |
| 136 | Acanthoma | 9.4% |
| 137 | Adenoma, Acidophil | 9.3% |
| 138 | Ganglioneuroma | 9.3% |
| 139 | Glioma | 9.3% |
| 140 | Malignant Glioma | 9.3% |
| 141 | Meningioma | 9.2% |
| 142 | Basal Cell Nevus Syndrome | 9.2% |
| 143 | Carcinoid Tumor | 9% |
| 144 | Neurilemmoma | 9% |
| 145 | Hutchinson's Melanotic Freckle | 9% |
| 146 | Melanoma, Amelanotic | 9% |
| 147 | Pouchitis | 9% |
| 148 | Sarcoma 180 | 8.9% |
| 149 | Rectal Fistula | 8.9% |
| 150 | Anal Fistula | 8.9% |
| 151 | Sarcoma, Experimental | 8.9% |
| 152 | Choriocarcinoma | 8.6% |
| 153 | Carcinoma, Lobular | 8.6% |
| 154 | Neoplasms, Radiation-Induced | 8.6% |
| 155 | Astrocytoma | 8.6% |
| 156 | Ependymoma | 8.6% |
| 157 | oligodendroglioma | 8.6% |
| 158 | Ganglioglioma | 8.6% |
| 159 | gliosarcoma | 8.6% |
| 160 | Anaplastic astrocytoma | 8.6% |
| 161 | Anaplastic Oligodendroglioma | 8.6% |
| 162 | Basal cell carcinoma | 8.5% |
| 163 | Carcinoma, Papillary | 8.5% |
| 164 | Squamous cell carcinoma | 8.5% |
| 165 | Chondrosarcoma | 8.5% |
| 166 | Craniopharyngioma | 8.5% |
| 167 | Crohn Disease | 8.5% |
| 168 | Cystadenoma | 8.5% |
| 169 | Duodenal Obstruction | 8.5% |
| 170 | leiomyosarcoma | 8.5% |
| 171 | liposarcoma | 8.5% |
| 172 | Mesothelioma | 8.5% |
| 173 | synovial sarcoma | 8.5% |
| 174 | Neuroectodermal Tumor, Melanotic | 8.5% |
| 175 | Angiomyolipoma | 8.5% |
| 176 | Clear Cell Sarcoma of Soft Tissue | 8.5% |
| 177 | Alveolar Soft Part Sarcoma | 8.5% |
| 178 | Neuroendocrine Tumors | 8.5% |
| 179 | Enterocolitis, Neutropenic | 8.5% |
| 180 | Necrotizing Enterocolitis | 8.5% |
| 181 | Sarcoma, Myeloid | 8.5% |
| 182 | Carcinoma, Basal Cell | 8.5% |
| 183 | Malignant Carcinoid Syndrome | 8.4% |
| 184 | Glioblastoma | 8.3% |
| 185 | Neuroblastoma | 8.3% |
| 186 | Glioblastoma Multiforme | 8.3% |
| 187 | Multiple Endocrine Neoplasia Type 1 | 8.2% |
| 188 | Fatty Liver, Alcoholic | 8.1% |
| 189 | Hepatitis, Alcoholic | 8.1% |
| 190 | Liver Cirrhosis, Alcoholic | 8.1% |
| 191 | Leukemia, Radiation-Induced | 8.1% |
| 192 | Ganglioneuroblastoma | 8.1% |
| 193 | Cystadenocarcinoma | 8% |
| 194 | Duodenal Ulcer | 8% |
| 195 | Fibrosarcoma | 8% |
| 196 | Osteosarcoma | 8% |
| 197 | Peptic Ulcer Perforation | 8% |
| 198 | Gastric ulcer | 8% |
| 199 | Mucoepidermoid Carcinoma | 8% |
| 200 | Adenofibroma | 7.8% |
| 201 | Fibroadenoma | 7.8% |
| 202 | Malignant Fibrous Histiocytoma | 7.8% |
| 203 | Bowen's Disease | 7.6% |
| 204 | Paraganglioma | 7.6% |
| 205 | Rhabdomyosarcoma | 7.6% |
| 206 | Giant Cell Tumor of Bone | 7.6% |
| 207 | Tuberous Sclerosis | 7.5% |
| 208 | Appendicitis | 7.5% |
| 209 | Thymoma | 7.5% |
| 210 | Leukemia, Plasma Cell | 7.4% |
| 211 | Endocrine Gland Neoplasms | 7.4% |
| 212 | Eye Neoplasms | 7.4% |
| 213 | Liver Diseases, Parasitic | 7.4% |
| 214 | Nervous System Neoplasms | 7.4% |
| 215 | Peutz-Jeghers Syndrome | 7.4% |
| 216 | Colonic Pseudo-Obstruction | 7.3% |
| 217 | Dermatofibrosarcoma | 7.3% |
| 218 | Dermatofibrosarcoma Protuberans | 7.3% |
| 219 | Bone neoplasms | 7.1% |
| 220 | Hepatic Veno-Occlusive Disease | 7.1% |
| 221 | Leukoplakia | 7.1% |
| 222 | Peliosis Hepatis | 7.1% |
| 223 | Skin Neoplasms | 7.1% |
| 224 | Hematologic Neoplasms | 7.1% |
| 225 | Hepatopulmonary Syndrome | 7.1% |
| 226 | Pheochromocytoma | 7.1% |
| 227 | Alveolar rhabdomyosarcoma | 7.1% |
| 228 | Retinoblastoma | 7.1% |
| 229 | Anus, Imperforate | 7% |
| 230 | Gastrointestinal Hemorrhage | 7% |
| 231 | Hemoperitoneum | 7% |
| 232 | Hepatomegaly | 7% |
| 233 | Histiocytic Disorders, Malignant | 7% |
| 234 | Actinic keratosis | 7% |
| 235 | Mesenteric Panniculitis | 7% |
| 236 | Neoplasm Invasiveness | 7% |
| 237 | Neoplasm Metastasis | 7% |
| 238 | Neoplasm Recurrence, Local | 7% |
| 239 | Panniculitis, Peritoneal | 7% |
| 240 | Peritonitis | 7% |
| 241 | Splenic Neoplasms | 7% |
| 242 | Peritoneal Fibrosis | 7% |
| 243 | Carcinogenesis | 7% |
| 244 | Encapsulating Peritoneal Sclerosis | 7% |
| 245 | Anorectal Malformations | 7% |
| 246 | Metastasis | 7% |
| 247 | Lymphomatoid Granulomatosis | 7% |
| 248 | Adenoma | 7% |
| 249 | Ameloblastoma | 7% |
| 250 | Angiokeratoma | 7% |
| 251 | Carcinoma | 7% |
| 252 | Cecal Diseases | 7% |
| 253 | Cholangitis | 7% |
| 254 | Cholecystitis | 7% |
| 255 | Cholestasis | 7% |
| 256 | Chordoma | 7% |
| 257 | Colonic Diseases | 7% |
| 258 | Common Bile Duct Diseases | 7% |
| 259 | Esophageal Stenosis | 7% |
| 260 | Hemangioma | 7% |
| 261 | hemangiopericytoma | 7% |
| 262 | Hepatitis, Chronic | 7% |
| 263 | Ileal Diseases | 7% |
| 264 | Intestinal Obstruction | 7% |
| 265 | Intestinal Perforation | 7% |
| 266 | Jejunal Diseases | 7% |
| 267 | Lymphangioma | 7% |
| 268 | Mesenchymoma | 7% |
| 269 | Nevus | 7% |
| 270 | Parathyroid Neoplasms | 7% |
| 271 | Pneumatosis Cystoides Intestinalis | 7% |
| 272 | Rectal Diseases | 7% |
| 273 | Retroperitoneal Neoplasms | 7% |
| 274 | Gastric Dilatation | 7% |
| 275 | Teratoma | 7% |
| 276 | Thyroid Neoplasm | 7% |
| 277 | Liver Failure | 7% |
| 278 | Gastric outlet obstruction | 7% |
| 279 | Hepatoblastoma | 7% |
| 280 | Mixed Tumor, Mullerian | 7% |
| 281 | Germinoma | 7% |
| 282 | Teratocarcinoma | 7% |
| 283 | Angiofibroma | 7% |
| 284 | Cronkhite-Canada Syndrome | 7% |
| 285 | Non-alcoholic Fatty Liver Disease | 7% |
| 286 | Chronic active hepatitis | 7% |
| 287 | Thyroid carcinoma | 7% |
| 288 | Intestinal Polyposis | 7% |
| 289 | Sarcoma | 7% |
| 290 | Epithelioma | 7% |
| 291 | Biliary Fistula | 7% |
| 292 | Gastric Fistula | 7% |
| 293 | Hepatic Vein Thrombosis | 6.9% |
| 294 | Liver Abscess | 6.9% |
| 295 | Budd-Chiari Syndrome | 6.9% |
| 296 | Tuberculosis, Gastrointestinal | 6.9% |
| 297 | Carcinoid Heart Disease | 6.9% |
| 298 | Composite Lymphoma | 6.7% |
| 299 | Enterocolitis, Pseudomembranous | 6.7% |
| 300 | pseudomembranous colitis | 6.7% |
| 301 | Dysentery, Bacillary | 6.7% |
| 302 | Acoustic Neuroma | 6.7% |
| 303 | Colitis, Ischemic | 6.5% |
| 304 | Tracheal Neoplasms | 6.4% |
| 305 | Hydatidiform Mole | 6.3% |
| 306 | Leukoplakia, Oral | 6.2% |
| 307 | Neurofibrosarcoma | 6.2% |
| 308 | Paraneoplastic Cerebellar Degeneration | 6.2% |
| 309 | Nephroblastoma | 6.2% |
| 310 | Radicular Cyst | 6% |
| 311 | Optic Nerve Glioma | 5.9% |
| 312 | Liver Abscess, Amebic | 5.8% |
| 313 | Endometrial Stromal Sarcoma | 5.8% |
| 314 | Adenocarcinoma | 5.7% |
| 315 | Cholestasis, Extrahepatic | 5.7% |
| 316 | Biliary Dyskinesia | 5.7% |
| 317 | Carcinoma in Situ | 5.7% |
| 318 | Carcinoma, Transitional Cell | 5.7% |
| 319 | Cholangitis, Sclerosing | 5.7% |
| 320 | Colonic Diseases, Functional | 5.7% |
| 321 | Phyllodes Tumor | 5.7% |
| 322 | Dysgerminoma | 5.7% |
| 323 | Esophageal motility disorders | 5.7% |
| 324 | Fecal Incontinence | 5.7% |
| 325 | Fecal Impaction | 5.7% |
| 326 | Hemangioendothelioma | 5.7% |
| 327 | Intussusception | 5.7% |
| 328 | Lipoma | 5.7% |
| 329 | Mallory-Weiss Syndrome | 5.7% |
| 330 | Megacolon | 5.7% |
| 331 | Myoma | 5.7% |
| 332 | Myxoma | 5.7% |
| 333 | Neuroma | 5.7% |
| 334 | Papilloma | 5.7% |
| 335 | Pseudomyxoma Peritonei | 5.7% |
| 336 | Pyloric Stenosis | 5.7% |
| 337 | Seminoma | 5.7% |
| 338 | Liver Failure, Acute | 5.7% |
| 339 | Papillomatosis | 5.7% |
| 340 | Angiolipoma | 5.7% |
| 341 | Myelolipoma | 5.7% |
| 342 | Neoplasms, Bone Tissue | 5.7% |
| 343 | Neoplasms, Fibrous Tissue | 5.7% |
| 344 | Smooth Muscle Tumor | 5.7% |
| 345 | Adenomatosis, Pulmonary | 5.7% |
| 346 | Adenomatous Polyps | 5.7% |
| 347 | Carcinoma, Large Cell | 5.7% |
| 348 | Carcinoma, Small Cell | 5.7% |
| 349 | Acalculous Cholecystitis | 5.7% |
| 350 | Desmoplastic Small Round Cell Tumor | 5.7% |
| 351 | End Stage Liver Disease | 5.7% |
| 352 | Chondroma | 5.7% |
| 353 | Ileus | 5.7% |
| 354 | Enchondroma | 5.7% |
| 355 | Meconium ileus | 5.7% |
| 356 | Chemical and Drug Induced Liver Injury | 5.7% |
| 357 | Thyroid Nodule | 5.6% |
| 358 | Lymphoma | 5.6% |
| 359 | Lymphangioleiomyomatosis | 5.6% |
| 360 | Hepatorenal Syndrome | 5.5% |
| 361 | Esophageal Perforation | 5.5% |
| 362 | Hepatitis, Animal | 5.5% |
| 363 | Hepatitis, Viral, Human | 5.5% |
| 364 | Intestinal Diseases, Parasitic | 5.5% |
| 365 | Hepatitis B, Chronic | 5.3% |
| 366 | Hepatitis C, Chronic | 5.3% |
| 367 | Deglutition Disorders | 5.3% |
| 368 | Mouth Neoplasms | 5.3% |
| 369 | Central Nervous System Neoplasms | 5.3% |
| 370 | Vascular Neoplasms | 5.3% |
| 371 | Limbic Encephalitis | 5.3% |
| 372 | Thymus Neoplasms | 5.3% |
| 373 | Achlorhydria | 5.2% |
| 374 | Genital Neoplasms, Female | 5.2% |
| 375 | Liver Cirrhosis, Experimental | 5.2% |
| 376 | Plasmacytoma | 5.2% |
| 377 | Gastric Antral Vascular Ectasia | 5.2% |
| 378 | Massive Hepatic Necrosis | 5.1% |
| 379 | Adenoid Cystic Carcinoma | 5.1% |
| 380 | Esophageal Achalasia | 5.1% |
| 381 | fibroma | 5.1% |
| 382 | Fibromatosis | 5.1% |
| 383 | Anal Fissure | 5.1% |
| 384 | Intestinal Pseudo-Obstruction | 5.1% |
| 385 | Irritable Bowel Syndrome | 5.1% |
| 386 | Osteoblastoma | 5.1% |
| 387 | Osteoma | 5.1% |
| 388 | Rhabdomyoma | 5.1% |
| 389 | Superior Mesenteric Artery Syndrome | 5.1% |
| 390 | Chondromatosis | 5.1% |
| 391 | Adenocarcinoma, Clear Cell | 5.1% |
| 392 | Cholangiocarcinoma | 5.1% |
| 393 | Cervical Intraepithelial Neoplasia | 5.1% |
| 394 | Hemangioblastoma | 5.1% |
| 395 | Emphysematous Cholecystitis | 5.1% |
| 396 | Neurogenic Bowel | 5.1% |
| 397 | Sphincter of Oddi Dysfunction | 5.1% |
| 398 | Lymphoma, Extranodal NK-T-Cell | 5.1% |
| 399 | Anal Ulcer | 5.1% |
| 400 | Malignant histiocytosis | 5.1% |
| 401 | Lymphatic Metastasis | 5.1% |
| 402 | Neoplasms, Unknown Primary | 5.1% |
| 403 | Peptic Ulcer Hemorrhage | 5.1% |
| 404 | Gastroparesis | 5.1% |
| 405 | Leukemic Infiltration | 5.1% |
| 406 | Breast Neoplasms, Male | 5.1% |
| 407 | Histiocytic sarcoma | 5.1% |
| 408 | Neoplasm Micrometastasis | 5.1% |
| 409 | Triple Negative Breast Neoplasms | 5.1% |
| 410 | Fibromatosis, Aggressive | 4.8% |
| 411 | Fibromatosis, Abdominal | 4.8% |
| 412 | Klatskin Tumor | 4.8% |
| 413 | Leydig Cell Tumor | 4.8% |
| 414 | Prolactinoma | 4.8% |
| 415 | Growth Hormone-Secreting Pituitary Adenoma | 4.8% |
| 416 | Lambert-Eaton Myasthenic Syndrome | 4.7% |
| 417 | Testicular Neoplasms | 4.7% |
| 418 | Porphyrias, Hepatic | 4.6% |
| 419 | Hemorrhoids | 4.3% |
| 420 | Autoimmune hepatitis | 4.3% |
| 421 | Mesoblastic Nephroma | 4.3% |
| 422 | Afferent Loop Syndrome | 4.3% |
| 423 | Celiac Disease | 4.3% |
| 424 | Meningeal Neoplasms | 4.3% |
| 425 | Short Bowel Syndrome | 4.3% |
| 426 | Sprue, Tropical | 4.3% |
| 427 | Steatorrhea | 4.3% |
| 428 | Rectocele | 4.3% |
| 429 | Sprue | 4.3% |
| 430 | Adrenocortical carcinoma | 4.2% |
| 431 | Diverticulitis | 4.2% |
| 432 | Dumping Syndrome | 4.2% |
| 433 | Leukemia, Myelomonocytic, Chronic | 4.2% |
| 434 | Rectal Prolapse | 4.2% |
| 435 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 4.2% |
| 436 | Adrenal Gland Neoplasms | 4.2% |
| 437 | Genital Neoplasms, Male | 4.2% |
| 438 | Uveal Neoplasms | 4.2% |
| 439 | Fascioliasis | 4.2% |
| 440 | Urologic Neoplasms | 4.2% |
| 441 | Echinococcosis, Hepatic | 4.1% |
| 442 | Melena | 4.1% |
| 443 | Opsoclonus-Myoclonus Syndrome | 4.1% |
| 444 | granulosa cell tumor | 4.1% |
| 445 | Carcinoma, Ovarian Epithelial | 4.1% |
| 446 | Sebaceous Gland Neoplasms | 4.1% |
| 447 | Spinal Neoplasms | 4.1% |
| 448 | Bone Marrow Neoplasms | 4.1% |
| 449 | Chemical and Drug Induced Liver Injury, Chronic | 4.1% |
| 450 | Reye Syndrome | 4.1% |
| 451 | Hematemesis | 4.1% |
| 452 | Hodgkin Disease | 4.1% |
| 453 | Lymphoma, Non-Hodgkin | 4.1% |
| 454 | Palatal Neoplasms | 4% |
| 455 | Nose Neoplasms | 3.8% |
| 456 | Mastocytoma | 3.8% |
| 457 | Pruritus Ani | 3.8% |
| 458 | Meningeal Carcinomatosis | 3.8% |
| 459 | Mastocytosis, Systemic | 3.8% |
| 460 | Leukemia, Myeloid, Chronic-Phase | 3.8% |
| 461 | Renal Cell Carcinoma | 3.7% |
| 462 | Papillary Renal Cell Carcinoma | 3.7% |
| 463 | Laryngopharyngeal Reflux | 3.7% |
| 464 | Myelitis, Transverse | 3.7% |
| 465 | Hepatitis, Viral, Animal | 3.6% |
| 466 | Carcinoma, Endometrioid | 3.6% |
| 467 | Denys-Drash Syndrome | 3.5% |
| 468 | Ear Neoplasms | 3.5% |
| 469 | Eyelid Neoplasms | 3.5% |
| 470 | Giardiasis | 3.5% |
| 471 | Lung Neoplasms | 3.5% |
| 472 | Pleural Neoplasms | 3.5% |
| 473 | Hepatitis E | 3.5% |
| 474 | Hepatitis B | 3.4% |
| 475 | Hepatitis C | 3.4% |
| 476 | Mastocytosis | 3.4% |
| 477 | Sturge-Weber Syndrome | 3.4% |
| 478 | Diverticulum | 3.4% |
| 479 | Hepatitis A | 3.4% |
| 480 | Diverticulosis | 3.4% |
| 481 | Cell Transformation, Viral | 3.4% |
| 482 | Brain Neoplasms | 3.4% |
| 483 | Salivary Gland Neoplasms | 3.4% |
| 484 | Spinal Cord Neoplasms | 3.4% |
| 485 | Tongue Neoplasms | 3.4% |
| 486 | Primary amyloidosis | 3.4% |
| 487 | Nasopharyngeal carcinoma | 3.4% |
| 488 | Hemangioma, Cavernous | 3.4% |
| 489 | Hepatic Encephalopathy | 3.4% |
| 490 | Pituitary Adenoma | 3.4% |
| 491 | Pituitary Neoplasms | 3.4% |
| 492 | Leukemia, T-Cell | 3.4% |
| 493 | Uterine Neoplasms | 3.4% |
| 494 | Vaginal Neoplasms | 3.4% |
| 495 | Vulvar Neoplasms | 3.4% |
| 496 | Uterine Cancer | 3.4% |
| 497 | Leukemia, B-Cell | 3.4% |
| 498 | Variegate Porphyria | 3.4% |
| 499 | Acute intermittent porphyria | 3.4% |
| 500 | Porphyria Cutanea Tarda | 3.4% |
| 501 | Fallopian Tube Neoplasms | 3.3% |
| 502 | neurofibroma | 3.3% |
| 503 | Lymphoma, Follicular | 3.3% |
| 504 | T-Cell Lymphoma | 3.3% |
| 505 | Mantle cell lymphoma | 3.3% |
| 506 | Bronchial Neoplasms | 3.1% |
| 507 | Multiple Pulmonary Nodules | 3.1% |
| 508 | Supratentorial Neoplasms | 3% |
| 509 | Endometrial Neoplasms | 3% |
| 510 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3% |
| 511 | Leukemia, Large Granular Lymphocytic | 3% |
| 512 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3% |
| 513 | Lymphoma, T-Cell, Cutaneous | 3% |
| 514 | Lymphoma, AIDS-Related | 3% |
| 515 | Enteropathy-Associated T-Cell Lymphoma | 3% |
| 516 | Primary Effusion Lymphoma | 3% |
| 517 | Pharyngeal Neoplasms | 2.9% |
| 518 | Dupuytren Contracture | 2.9% |
| 519 | ovarian neoplasm | 2.9% |
| 520 | Urticaria Pigmentosa | 2.9% |
| 521 | Central Nervous System Cysts | 2.9% |
| 522 | Penile Neoplasms | 2.8% |
| 523 | Prostatic Neoplasms | 2.8% |
| 524 | Brain Stem Neoplasms | 2.8% |
| 525 | Mycosis Fungoides | 2.8% |
| 526 | Lymphomatoid Papulosis | 2.8% |
| 527 | Plasmablastic lymphoma | 2.8% |
| 528 | Lactose Intolerance | 2.8% |
| 529 | Polycythemia Vera | 2.8% |
| 530 | Choroid Plexus Papilloma | 2.7% |
| 531 | Xeroderma Pigmentosum | 2.7% |
| 532 | Hypopharyngeal Neoplasms | 2.5% |
| 533 | Pleural Effusion, Malignant | 2.5% |
| 534 | Hypopharyngeal Cancer | 2.5% |
| 535 | Waldenstrom Macroglobulinemia | 2.5% |
| 536 | Multiple Myeloma | 2.5% |
| 537 | Laryngeal neoplasm | 2.5% |
| 538 | Parotid Neoplasms | 2.5% |
| 539 | Prostatic Neoplasms, Castration-Resistant | 2.5% |
| 540 | Nelson Syndrome | 2.5% |
| 541 | Bladder Neoplasm | 2.4% |
| 542 | Kidney Neoplasm | 2.4% |
| 543 | Ureteral Neoplasms | 2.4% |
| 544 | Urethral Neoplasms | 2.4% |
| 545 | Tonsillar Neoplasms | 2.4% |
| 546 | Cerebellar Neoplasms | 2.3% |
| 547 | Zellweger Syndrome | 2.2% |
| 548 | Cryptosporidiosis | 2.1% |
| 549 | Burkitt Lymphoma | 2.1% |
| 550 | Hepatolenticular Degeneration | 2% |
| 551 | Sezary Syndrome | 2% |
| 552 | Rift Valley Fever | 1.9% |
| 553 | Nasopharyngeal Neoplasms | 1.9% |
| 554 | CREST Syndrome | 1.9% |
| 555 | Paranasal Sinus Neoplasms | 1.7% |
| 556 | Maxillary Sinus Neoplasms | 1.6% |
